SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-223200
Filing Date
2018-07-23
Accepted
2018-07-23 09:02:02
Documents
34
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d557556d10q.htm 10-Q 202365
2 EX-31.1 d557556dex311.htm EX-31.1 6258
3 EX-31.2 d557556dex312.htm EX-31.2 6258
4 EX-32.1 d557556dex321.htm EX-32.1 2780
5 EX-32.2 d557556dex322.htm EX-32.2 2859
  Complete submission text file 0001193125-18-223200.txt   1499428

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT hppi-20180630.xml EX-101.INS 172442
7 XBRL TAXONOMY EXTENSION SCHEMA hppi-20180630.xsd EX-101.SCH 24912
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hppi-20180630_cal.xml EX-101.CAL 23017
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hppi-20180630_def.xml EX-101.DEF 94704
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hppi-20180630_lab.xml EX-101.LAB 199048
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hppi-20180630_pre.xml EX-101.PRE 135616
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13467 | Film No.: 18963677
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 9